---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-003784"
form_type: "8-K"
ticker: "BAX"
cik: "0000010456"
company_name: "BAXTER INTERNATIONAL INC"
filed_at: "2024-02-08T23:59:59+00:00"
generated_at: "2026-06-06T05:12:31.743871+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Baxter Q4 sales $3.89B (+4%); full-year adj. EPS $2.60

## Summary
- Q4 sales from continuing ops $3.89B (+4% reported, +3% constant currency); GAAP EPS $0.14, adjusted EPS $0.88.
- Full-year 2023 sales $14.81B (+2% reported, +3% constant currency); GAAP diluted loss ($0.15), adjusted EPS $2.60.
- Company progressed on new operating model, sale of BioPharma Solutions, and planned Kidney Care separation.
- CEO cited building momentum and improving macroeconomic/supply chain environment in 2023.

## SEC filing metadata
- accession: 0001628280-24-003784
- form_type: 8-K
- ticker: BAX
- cik: 0000010456
- company_name: BAXTER INTERNATIONAL INC
- filed_at: 2024-02-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10456/000162828024003784/0001628280-24-003784-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10456/000162828024003784/bax-20240208.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-003784
- JSON: https://secwatch.observer/filing/0001628280-24-003784.json
- Plain text: https://secwatch.observer/filing/0001628280-24-003784.txt

## Key facts
- Earnings Releases
  BAXTER INTERNATIONAL INC reported the full year ended Dec. 31, 2023 results: revenue $14.81 billion, EPS ($0.15). Guidance initiated.
  - Period: the full year ended Dec. 31, 2023
  - Revenue: $14.81 billion
  - EPS: ($0.15)
  - Guidance: initiated
  - Result: reported results
  source text: Full-year sales from continuing operations of $14.81 billion increased 2% on a reported basis and 3% on a constant currency basis • Full-year U.S. GAAP diluted EPS (loss) from continuing operations of ($0.15) and adjusted diluted EPS from continuing operations of $2.60
  evidence_url: https://www.sec.gov/Archives/edgar/data/10456/000162828024003784/0001628280-24-003784-index.htm
- Earnings Releases
  BAXTER INTERNATIONAL INC reported the fourth quarter ended Dec. 31, 2023 results: revenue $3.89 billion, EPS $0.14. Guidance initiated.
  - Period: the fourth quarter ended Dec. 31, 2023
  - Revenue: $3.89 billion
  - EPS: $0.14
  - Guidance: initiated
  - Result: reported results
  source text: Fourth-quarter sales from continuing operations of $3.89 billion increased 4% on a reported basis and 3% on a constant currency basis 1 • Fourth-quarter U.S. GAAP diluted earnings per share (EPS) from continuing operations of $0.14 and adjusted diluted EPS from continuing operations of $0.88
  evidence_url: https://www.sec.gov/Archives/edgar/data/10456/000162828024003784/0001628280-24-003784-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.